Guizhou Yibai Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guizhou Yibai Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Hengkang Medical Group Co Ltd
sales of 3.84 billion Chinese Renmimbi [US$548.51 million]
of which 84%
was Medical service),
Jiangsu Kanion Pharmaceutical Co., Ltd.
(3.82 billion Chinese Renmimbi [US$546.42 million]
of which 100%
was Domestic Sales of Industrial Enterprises), and
Beijing Aosaikang Pharmaceutical Co Ltd
(3.93 billion Chinese Renmimbi [US$561.87 million]
of which 99%
was Pharmaceutical manufacturing).
During the year ended December of 2018, sales at
Guizhou Yibai Pharmaceutical Co., Ltd. were 3.88 billion Chinese Renmimbi (US$554.86 million).
a very small
increase of 2.0%
versus 2017, when the company's sales were 3.81 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Guizhou Yibai Pharmaceutical Co., Ltd.
(and since 2013, sales have increased a total of 39%).
Sales of Medical Service saw an increase
that was more than double the company's growth rate: sales were up
22.4% in 2018, from
718.51 million Chinese Renmimbi to 879.77 million Chinese Renmimbi.
Not all segments of Guizhou Yibai Pharmaceutical Co., Ltd. experienced an increase in sales in 2018:
sales of Medical Industry fell 3.1% to 2.99 billion Chinese Renmimbi.